期刊名称：CELLULAR REPROGRAMMING
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Cellular Reprogramming, (formerly Cloning and Stem Cells), reflects the new focus in this evolving field. Advances in reprogramming cellular mechanisms are transforming biomedical research and should offer new insights on the etiology, development, and potential treatment of various diseases. Cloning and Stem Cells, which has long focused on many aspects of cellular reprogramming, has been renamed in recognition of the rapidly increasing importance of this particular biological field of study. The Journal will emphasize novel approaches for understanding the cellular and molecular mechanisms that underlie the phenomenon of reprogramming. The Journal will continue to publish papers concerned with:
1. Somatic cell nuclear transfer and reprogramming in early embryos
2. Embryonic stem cells
3. Nuclear transfer stem cells (stem cells derived from nuclear transfer embryos)
4. Generation of induced pluripotent stem (iPS) cells and/or potential for cell-based
5. therapies
6. Epigenetics
7. Adult stem cells and pluripotency
8. And much more…
Indexed/Abstracted in:
MEDLINE; EMBASE/Excerpta Medica; Science Citation Index Expanded; BIOSIS Previews; Biotechnology Citation Index®; Biological Abstracts; Chemical Abstracts; EMBiology; Scopus; CAB Abstracts
Instructions to Authors
Cellular Reprogramming (formerly Cloning and Stem Cells) is proud to announce the launch of its web-based manuscript submission and peer-review system called Manuscript Central.
We invite all authors to submit online any new manuscripts that are to be considered for publication. Please use the following URL: http://mc.manuscriptcentral.com/cellreprogramming
For further information or questions about articles in the peer-review process, please contact Jane Taylor at jane.taylor@ed.ac.uk
For technical information on using Manuscript Central, contact Adam Etkin at (914) 740-2100, ext. 2128 or aetkin@liebertpub.com.
Instructions for Authors
Cellular Reprogramming is a peer-reviewed journal that publishes original research articles, review papers, and short communications. Contributions are welcome in the fields of oocyte maturation, activation, fusion, cell cycle, gene expression, embryo culture, and embryo transfer as it relates to nuclear transfer; embryonic stem cells, primordial germ cells, and somatic cell lines, including their genetic modification (as it relates to nuclear transfer); and production of pharmaceutical proteins in milk by cloning, and tissue and organ therapy (xenotransplantation) using cloned animals and germ line gene therapy.
The Journal will also publish LiteratureWatches, Web-Watches, Point/Counterpoints, News and Comments, including Meetings, and Book Reviews. Editor-in-Chief: Professor Sir Ian Wilmut OBE FRS FRSE, Associate Editor: Bryon E. Petersen, Ph.D.
Manuscript Submission and Copyright Agreement Form.
The Copyright Agreement form (available from web site at http://www.liebertpub.com/media/content/transfer_of_copyright.pdf ) should be submitted once your paper has been accepted for publication. Manuscripts cannot be published without this form. The corresponding author is responsible for obtaining signatures of coauthors. Authors not permitted to release copyright must still return the form signed under the statement of the reason for not releasing the copyright. Upon acceptance of your paper, please fax the Copyright Agreement form to 914-740-2108.
Preparation of Manuscript
Animal Ethics
The editor acknowledges that all animals are creatures of great value and remarkable complexity. The use of animals in research can contribute uniquely to the advancement of scientific knowledge, and thus, ultimately, to improvements in human health or welfare of humans and animals. Please include in your manuscript a description of the regulatory framework that monitored the animal welfare in your institution.
Research Papers
Manuscripts should be submitted double-spaced in Microsoft Word. Leave ample margins on both sides, top and bottom.
Be prepared to enter:
• A running title of 40 characters including spaces.
• Supply an abstract of about 200 words, stating the aims, results, and conclusions drawn from the study. Reference citations are not permitted in the abstract.
• Your submission should display the following in this order: Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, and the tables and figure legends. Results and Discussion should be separate sections.
• Authors should review the style and clarity of their manuscripts with colleagues before submission.
Please follow the protocol described herein to avoid delay in publication. Authors should note that manuscripts may be edited if needed to ensure clear grammatical English usage. The editors welcome suggestions concerning potential reviewers.
Brief Reports
Submission of Brief Reports is also welcome. A Brief Report should communicate new methodological information in the fields of mammalian cloning, transgenics, and cell and tissue therapy. It should be divided as follows: Abstract (no more than 200 words), Introduction, Materials and Methods, Results, Discussion (please consider that in Brief Reports, Results and Discussion can be combined), Acknowledgments, References, and tables and figure legends.
The whole report should be composed of no more than four journal pages (about 3,000 words), including tables and figures. For general rules, please follow the guidelines given for Research Papers.
Tables and Illustrations
Use Arabic numerals to number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences. Explain abbreviations used in the body of the table in footnotes. If the table is taken from a copyrighted publication, credit must be given in a footnote.
A legend should be supplied for each illustration, and all legends should be typed (double-spaced) and numbered consecutively at the end of the manuscript. Figures should be numbered in the order cited in the text. Images should not show the name of the manufacturer.
Please follow these guidelines when submitting figures:
• Do not include any illustrations as part of your text file.
• Do not prepare any figures in Word as they are not workable.
• Line illustrations must be submitted at 1200 DPI.
• Halftones and color images should be submitted at a minimum of 300 DPI.
• Adobe is the preferred software. DO NOT submit PowerPoint files.
• Save art as either TIFFor EPS files. Avoid submitting JPEG files.
• Color art must be saved as CYMK not RGB.
The Journal will publish color photographs, but the author will be charged for the cost of color separations and printing at the rate of $275 per piece of color art plus $1,200 per page of color. The Publisher will provide the author with a more precise cost estimate when the figures are received. For further details, contact the Editor or Publisher.
AUTHOR DISCLOSURE
All authors are expected to disclose any institutional or commercial affiliations that might pose a conflict of interest regarding the publication of a manuscript. Institutional affiliations, as indicated on the title page, should include all corporate affiliations and any funding sources that support the work. Other types of affiliation, including consultantships, honoraria, stock ownership, equity interests, arrangements regarding patents, or other vested interests should be disclosed in the Acknowledgments section.
References
All references should be cited by authors and dates within the text (citations are not permitted in the abstract):
i.e. The ribosomal RNA (rrn) operons in E. coli contain single copies of each of the 16S, 23S, and 5S r(RNA) genes (Pace, 1973).
If more than two authors are involved, use et al. after the first author’s name:
i.e. (Wells, et al., 1997).
If several article by the same authors are cited in one sentence, use a lower case letter designation to indicate the individual papers:
i.e. (Dunn and Studier, 1973a, 1973b). Use same designation in reference list.
All references in the bibliography should be double spaced and listed in alphabetical order at the end of the paper. References should include the complete titles of cited papers and all authors:
Journal citation: Pace, N. (1973). Structure and synthesis of the ribosomal ribonucleic acid of prokaryotes. Bacteriol. Rev. 37, 562–603.
Book citation: Brosius, J. (1987). Expression vectors employing l, trp, lac, and lpp-derived promoters. In Vectors, a Survey of Molecular Cloning Vectors and Their Uses. R.L. Rodriguez and D.T. Denhardt, eds. (Butterworth Publishers, Stoneham, MA) pp. 205–225.
When data from an unpublished source are given, supply the researcher’s name. If the work is in press, give the journal in which it is to be published or the name of the publisher. Abbreviations of journal names should follow the style of MEDLINE.
PERMISSIONS
The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained from the publisher of the journal or book concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote of a reprinted table, or of the legend of a reprinted figure, should read “reprinted by permission from Jones et al.” and list the appropriate reference. All permissions listings must be shown in the manuscript—they cannot be entered on proofs. Manuscripts submitted to this Journal must not be under consideration elsewhere.
REPRINTS
Reprints may be ordered by using the special reprint order form that will accompany the proofs. Reprints ordered after the issue is printed will be charged at a higher rate.
PUBLISHER
The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, 3rd Floor, New Rochelle, NY 10801-5215. Telephone: (914) 740-2100; fax: (914) 740-2102; e-mail: info@liebertpub.com on-line: www.liebertpub.com
Editorial Board
Editor-in-Chief
Professor Sir Ian Wilmut, OBE FRS FRSE
Director
Centre for Regenerative Medicine
University of Edinburgh
GU.426 Chancellor's Building
49 Little France Crescent
Edinburgh EH16 4SB
Tel: 0131 242 6630
Fax: 0131 242 6629
Deputy Editor
Jane Taylor, PhD
Centre for Regenerative Medicine
University of Edinburgh
Edinburgh, Scotland
jane.taylor@ed.ac.uk
Editorial Board
Ken Bondioli, PhD
Louisiana State University Agricultural College
Baton Rouge, LA
Keith H.S. Campbell, DPhil
University of Nottingham
Leicestershire, UK
Arthur L. Caplan, PhD
University of Pennsylvania
Philadelphia, PA
R. Alta Charo, JD
University of Wisconsin Law School
Madison, WI
Jose Bernardo Cibelli, DVM, PhD
Michigan State University
East Lansing, MI
Pete Coffey, BSc, DPhil
University College London
London, United Kingdom
Jacques Cohen, PhD
Saint Barnabas Medical Center
West Orange, NJ
Philippe Collas, PhD
University of Oslo
Oslo, Norway
Tanja Dominko, DVM, PhD
Bioengineering Institute
Worcester, MA
John J. Eppig, PhD
The Jackson Laboratory
Bar Harbor, ME
Will Eyestone, PhD
Virginia-Maryland Regional College of Veterinary Medicine
Blacksburg, VA
Loren J. Field, PhD
Indiana University Medical Center
Indianapolis, IN
Neal First, PhD
University of Wisconsin-Madison
Madison, WI
Josef Fulka, Jr., PhD
Institute of Animal Science
Prague, Czech Republic
Fred Gage, PhD
The Salk Institute for Biological Studies
La Jolla, CA
Cesare Galli, DVM
Laboratorio di Tecnologie della Riproduzione, Cremona
Università di Bologna, Italy
Shaorong Gao, PhD
National Institute of Biological Sciences
Beijing, China
John D. Gearhart, PhD
Johns Hopkins Hospital
Baltimore, MD
Markus Grompe, MD
Oregon Health Sciences University
Portland, OR
William A. Haseltine, PhD
Washington, DC
Joseph Itskovitz-Eldor, MD DSc
Israel Institute of Technology
Haifa, Israel
Jiri Kanka, PhD
Institute of Animal Physiology and Genetics
Libechov, Czech Republic
Carol Keefer, PhD
University of Maryland
College Park, MD
Hiroshi Kubota, DVM, PhD
University of Pennsylvania
Philadelphia, PA
Keith Latham, PhD
Temple University
Philadelphia, PA
Lorraine Leibfried-Rutledge, PhD
Biomed, Inc.
Madison, WI
Lingsong Li, MD, PhD
Peking University Health Science Center
Beijing, China
Poul Maddox-Hyttel, DVM, PhD, DVSc
Royal Veterinary and Agricultural University
Frederiksberg, Denmark
Ronald D. McKay, PhD
NIH/NINDS/LMB
Bethesda, MD
Jan Motlik, PhD
Institute of Animal Physiology and Genetics
Libechov, Czech Republic
Takashi (Taku) Nagai, PhD
National Institute of Agrobiological Sciences
Ibaraki, Japan
Hiroshi Nagashima, PhD
Meiji University
Tama, Japan
Huck Hui Ng, PhD
Genome Institute of Singapore
Singapore
Heiner Niemann, PhD
Institut fur Tierzucht und Tieverhalten
Neustadt, Germany
Jorge Piedrahita, PhD
North Carolina State University
Raleigh, NC
Kathrin Plath, PhD
UCLA School of Medicine
Los Angeles, CA
Randall S. Prather, PhD
University of Missouri-Columbia
Columbia, MO
Jean-Paul Renard, PhD
INRA
Jouy en Josas, France
Benjamin Reubinoff, MD, PhD
Hadassah University Medical Center, Ein Kerem
Jerusalem, Israel
James Robl, PhD
HEMATECH, INC.
Sioux Falls, SD
Gerald Schatten, PhD
University of Pittsburgh School of Medicine
Pittsburgh, PA
Hans R. Schoeler, PhD
Max-Planck Institute for Molecular Biomedicine
Muenster, Germany
Austin G. Smith (hons.), PhD
University of Cambridge
Cambridge, United Kingdom
Lawrence L. Smith, PhD
University of Montreal, Canada
Davor Solter, MD, PhD
Max-Planck-Institute of Immunobiology
Freiburg, Germany
Alan Trounson, PhD
California Institute for Regenerative Medicine
San Francisco, CA
Gábor Vajta, MD, PhD, DVSc
James Cook University
Cairns, Queensland
Catherine M. Verfaillie, MD
Katholieke Universiteit Leuven
Leuven, Belgium
Angelo L. Vescovi, PhD
Institute for Stem Cell Research
Milan, Italy
Júlio Voltarelli, MD PhD
University of São Paulo,
São Paulo, Brazil
Irv L. Weissman, MD
Stanford University Medical Center
Stanford, CA
David Wells, PhD
AgResearch
Hamilton, New Zealand
Mark E. Westhusin, PhD
Texas A&M University
College Station, TX
Kenneth L. White, PhD
Utah State University
Logan, UT
Ryuzo Yanagimachi, PhD
University of Hawaii Medical School
Honolulu, HI
| 
